Alexandre Paccalet, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Hypoxia | 1 | 2019 | 659 | 0.580 |
Why?
|
| Myocytes, Cardiac | 2 | 2020 | 1611 | 0.470 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2024 | 474 | 0.320 |
Why?
|
| Oxygen | 1 | 2019 | 4182 | 0.310 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2021 | 634 | 0.290 |
Why?
|
| Cardiotonic Agents | 2 | 2020 | 533 | 0.280 |
Why?
|
| Brain Ischemia | 4 | 2022 | 3072 | 0.250 |
Why?
|
| Interleukin-6 | 4 | 2022 | 3161 | 0.230 |
Why?
|
| Myoglobin | 1 | 2024 | 159 | 0.230 |
Why?
|
| Stroke | 6 | 2022 | 9693 | 0.220 |
Why?
|
| Thrombectomy | 3 | 2022 | 676 | 0.200 |
Why?
|
| Osteopontin | 1 | 2023 | 296 | 0.190 |
Why?
|
| Septal Occluder Device | 1 | 2021 | 131 | 0.180 |
Why?
|
| Meningitis, Bacterial | 1 | 2022 | 220 | 0.170 |
Why?
|
| Medical Futility | 1 | 2020 | 123 | 0.170 |
Why?
|
| Collateral Circulation | 1 | 2020 | 276 | 0.170 |
Why?
|
| Foramen Ovale, Patent | 1 | 2021 | 212 | 0.160 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2019 | 295 | 0.160 |
Why?
|
| Oxidation-Reduction | 1 | 2024 | 2187 | 0.150 |
Why?
|
| Chemokine CCL2 | 1 | 2020 | 598 | 0.150 |
Why?
|
| Fibrinogen | 1 | 2021 | 866 | 0.150 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2020 | 398 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2021 | 572 | 0.140 |
Why?
|
| Prosthesis Implantation | 1 | 2021 | 595 | 0.140 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2022 | 613 | 0.140 |
Why?
|
| Microcirculation | 1 | 2021 | 1284 | 0.130 |
Why?
|
| Coronary Circulation | 1 | 2021 | 1558 | 0.120 |
Why?
|
| Myocardium | 2 | 2024 | 4634 | 0.110 |
Why?
|
| Reperfusion Injury | 1 | 2020 | 1005 | 0.110 |
Why?
|
| Carotid Stenosis | 1 | 2020 | 850 | 0.110 |
Why?
|
| C-Reactive Protein | 2 | 2022 | 3752 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 2075 | 0.100 |
Why?
|
| Calcinosis | 1 | 2020 | 1415 | 0.100 |
Why?
|
| Mitochondria | 2 | 2020 | 3529 | 0.090 |
Why?
|
| Cell Survival | 1 | 2019 | 5764 | 0.090 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2020 | 1487 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2019 | 5843 | 0.080 |
Why?
|
| Hemorrhage | 1 | 2021 | 3521 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2019 | 3033 | 0.080 |
Why?
|
| Macrophages | 1 | 2023 | 5664 | 0.080 |
Why?
|
| Calcium | 1 | 2020 | 5656 | 0.070 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 2030 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 21600 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 5052 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2024 | 11661 | 0.050 |
Why?
|
| Puromycin | 1 | 2020 | 43 | 0.050 |
Why?
|
| Sodium Fluoride | 1 | 2020 | 62 | 0.050 |
Why?
|
| Reperfusion | 1 | 2021 | 264 | 0.050 |
Why?
|
| Excitation Contraction Coupling | 1 | 2020 | 24 | 0.050 |
Why?
|
| France | 1 | 2021 | 500 | 0.040 |
Why?
|
| Mice | 3 | 2023 | 80264 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2021 | 15365 | 0.040 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2020 | 178 | 0.040 |
Why?
|
| Cerebrospinal Fluid | 1 | 2022 | 538 | 0.040 |
Why?
|
| Animals | 5 | 2024 | 166578 | 0.040 |
Why?
|
| Aged | 8 | 2022 | 164457 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2021 | 692 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2024 | 1975 | 0.040 |
Why?
|
| Inflammation | 3 | 2022 | 10635 | 0.040 |
Why?
|
| Skull | 1 | 2022 | 808 | 0.040 |
Why?
|
| Male | 8 | 2024 | 351538 | 0.040 |
Why?
|
| Heart Atria | 1 | 2023 | 1321 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2021 | 1580 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2024 | 2662 | 0.030 |
Why?
|
| Prognosis | 3 | 2021 | 29078 | 0.030 |
Why?
|
| Humans | 15 | 2023 | 746839 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2023 | 2665 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2020 | 2616 | 0.030 |
Why?
|
| Carotid Artery Diseases | 1 | 2020 | 862 | 0.030 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2023 | 1403 | 0.030 |
Why?
|
| Kinetics | 1 | 2021 | 6362 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2022 | 2042 | 0.030 |
Why?
|
| Middle Aged | 6 | 2022 | 214698 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2021 | 53268 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2022 | 2904 | 0.020 |
Why?
|
| Cell Movement | 1 | 2023 | 5166 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2022 | 63767 | 0.020 |
Why?
|
| Mortality | 1 | 2021 | 2855 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2022 | 35800 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2020 | 9600 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2021 | 3706 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2021 | 5142 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 12021 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 57622 | 0.020 |
Why?
|
| Female | 5 | 2021 | 382565 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 17870 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15012 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 6419 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2021 | 78360 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 40538 | 0.010 |
Why?
|
| Adult | 2 | 2021 | 215288 | 0.010 |
Why?
|
| Brain | 1 | 2022 | 26598 | 0.010 |
Why?
|